Session 2 - Cardio-Oncology Around the Globe

Dr Alicia Okines is a Consultant Medical Oncologist specializing in breast cancer and acute oncology at the Royal Marsden Hospital in London, and Honorary Faculty at the Institute of Cancer Research in London. Dr Okines studied Pharmacology and then Medicine at the University of Sheffield. During her specialist medical oncology training at the Royal Marsden Hospital, she completed an MD(Res) investigating VEGF and EGFR targeting at the Institute of Cancer Research. Her research interests principally lie in clinical trials and translational research in metastatic breast cancer including brain disease. She is currently leading multi-centre studies in lobular breast cancer and androgen-receptor positive triple negative breast cancer. She has widely published in peer-reviewed journals.

Dr. Andrés j. Daniele is a Head of Cardio-Oncology Department al Instituto de Oncología "Ángel H. Roffo", Buenos Aires University. He earned his MD degree at La Plata University and completed his residency in cardiology at Favaloro Foundation.. He developed cardio-oncology in Argentina for ten years and actually he is president of Asociación de Cardio-Oncología de la República Argentina and the International CardiOncology - Chapter Argentina.

Dr. Garza is the head of cardio-oncology in Oncare Treatment center, the largest private oncology clinic in the north of the Mexico. His completed his training in internal medicine and cardiology in Monterrey Mexico, followed by a cardio-Oncology fellowship at the Royal Brompton Hospital in London. He is also president of the Mexican chapter of IC-OS. His research interests include cardiac imaging and surveillance in patients with positive HER-2 breast cancer .

Geeta Gulati, M.D, PhD is a consultant cardiologist in cardio-oncology at Oslo University Hospital, Ullevaal, Norway and a senior researcher at Akershus University Hospital, Lorenskog & University of Oslo, Norway. She has established two cardio-oncology units in Norway. Her primary research focus is Randomized Controlled Trials in cardioprotection during cancer treatment. Dr Gulati is the Secretary of the Norwegian Cardiology Society, founder and chair of the Nordic Cardio-Oncology Society and a nucleus member of European Society of Cardiology, Cardio-Oncology Council.

Permanent faculty, associate professor at Universidade de São Paulo Medical School. Cardio-Oncology Coordinator at Instituto do Coração, Hospital das Clínicas, FMUSP. Cardiology Coordinator of the Cancer Institute of the State of São Paulo (ICESP). Coordinator of the Intensive Care Unit at Hospital Paulistano. Coordinator of Cardio-Oncology of the Americas Serviços Médicos Network and director of Science, Innovation and Technology of the Brazilian Society of Cardiology. Participates in the Medical Residency Program and is an advisor of this Graduate Program. Assistance, teaching and research activities.

Head of Department of Clinical Pharmacology and Cardio-Oncology, Head of Cardio-Oncology Center of National Scientific Center «Institute of Cardiology named by M.D.Strazhesko», Kyiv, Ukraine. He has developed cardio-oncology direction in Ukraine and is a Leader of the Cardio-oncology Working Group of Ukrainian Association of Cardiology and the International Cardio-Oncology Society - Chapter Ukraine. His research focuses on designing and implementing strategies to help prevent cardiotoxicity in cancer patients.

President of Dalian Medical University Cardiovascular Hospital. Vice Chairman of Youth Committee of Chinese Association of Cardiac Pacing and Electrophysiology Vice Chairman of Youth Committee of Heart Failure Branch of Chinese Medical Doctor Association Vice Chairman of Liaoning Medical Association Cardiology Branch Standing Committee Member, Liaoning Medical Association Electrophysiology and Pace Branch Vice Chairman of the Electrophysiology and Pacing Branch of Dalian Medical Association Vice chairman of Dalian Medical Association Scientific Research Management Branch Director of Liaoning Medical Doctor Association Youth member of Chinese Association of Cardiology Member of the Organizing Committee of Liaoning Medical Doctor Association Member of Arrhythmia Committee of Cardiovascular Disease Branch of Chinese Medical Doctor Association Specialities: The research on the mechanism of atrial arrhythmias (including atrial fibrillation) and catheter ablation treatment, the research on the mechanism of heart failure and electrocardiographic dyssynchron, ventricular hypertrophy and ventricular fibrosis, and the basic and clinical early warning research on the occurrence of ventricular malignant arrhythmias in heart failure

Zaza Iakobishvili, MD, PhD is a director of Community Cardiology Department in Tel Aviv district of Clalit Health Services since 2018. Dr. Iakobishvili received his MD/PhD in 1988 from the Tbilisi State Medical University and Tbilisi Institute of Human Physiology. He is board certified in internal medicine (1998) and cardiology (2001) in Israel. He worked as attending physician in the cardiac intensive care unit in Rabin Medical Center, Beilinson hospital in 2002-2017. In 2015-2019 he served elected chairman of the Acute Cardiac Care working group and led Acute Coronary Syndrome Israeli Registry (ACSIS). He takes active participation in the ESC ACCA working group on quality of acute cardiac care. In 2018 he was appointed a board member of cardio-oncology study group in Heart Failure Association of ESC. He has established first dedicated cardio-oncology clinic in the Rabin Medical Center in 2013 and chairs the committee of Israel Ministry of Health on cardio-oncology.He organized in 2015 and 2017 the first International cardio-oncology meetings in Israel. Dr. Iakobishvili is actively engaged in the organization of community heart failure and cardio-oncology clinics in Israel. Recently he was appointed to serve as an international advisor for the Journal of American College of Cardiology – Cardio-oncology editorial board. He already serves on the editorial board of Cardio-Oncology, affiliated with the International Cardio-Oncology Society.